The "VISION" Trial: Ventavis Inhalation With Sildenafil to Improve and Optimize Pulmonary Arterial Hypertension

NCT00302211 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

67

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated due to slow enrollment

Conditions

Pulmonary Hypertension

Interventions

DRUG: Inhaled Iloprost (5 μg)
DRUG: Inhaled Placebo
DRUG: Sildenafil
DRUG: Bosentan

Sponsor

Actelion